BioLumen

San Francisco, United States Founded: 2018 • Age: 8 yrs
Organic ingredient processing company
Annual revenue - Latest available
Total funding $250,000 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About BioLumen

BioLumen is a company based in San Francisco (United States) founded in 2018. BioLumen has raised $250 thousand across 1 funding round from investors including IndieBio.

  • Headquarter San Francisco, United States
  • Sectors
    Consumer
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Consumer → Food & Beverage Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $250 K (USD)

    in 1 rounds

  • Latest Funding Round
    $250 K (USD), Seed

    Nov 01, 2019

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of BioLumen

Headcount 1-10
Employee Profiles 3
Board Members and Advisors 2
Employee Profiles
People
Paolo Costa
CEO & Founder
People
Robert H. Lustig
Chief Medical Officer
People
Atoosa Maleki
Chief Science Officer

Unlock access to complete

Board Members and Advisors
people
Pablo Zamora
Advisor
people
Lance Lively
Advisor

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of BioLumen

BioLumen has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in BioLumen

BioLumen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IndieBio.

All
Venture Fund
Investor Description Founded Year Domain Location
Biotech startups are accelerated through IndieBio's focused programs.
Locked Locked Locked
Premium access

Investor details for BioLumen

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioLumen

Investments
Premium access

Investment portfolio details for BioLumen

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioLumen

Premium access

Detailed financials for BioLumen

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biolumen Comparisons

BioLumen Primary company
Description
Organic ingredient processing company
Location
San Francisco, United States
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for BioLumen

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioLumen

Premium access

Detailed competitors of BioLumen

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biolumen

Premium access

Complete news archive for BioLumen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioLumen

BioLumen was founded in 2018 and raised its 1st funding round 1 year after it was founded.

BioLumen is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

BioLumen is a funded company, having raised a total of $250K across 1 funding round to date.

BioLumen, founded in 2018 in San Francisco, United States, focuses on food and agriculture, food processing, food ingredients, and multi-category. Organic ingredient processing company. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

BioLumen has 1 investor. Key investors include IndieBio.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available